Efatutazone hydrochloride is an orally bioavailable, high-affinity PPAR-γ agonist with with antineoplastic activity. References: Aprile G, Giuliani F, Lutrino SE, Fontanella C, Bonotto M, Rihawi K, Fasola G. Maintenance Therapy in Colorectal Cancer: Moving the Artillery Down While Keeping an Eye on the Enemy. Clin Colorectal Cancer. 2016 Mar;15(1):7-15. doi: 10.1016/j.clcc.2015.08.002. Epub 2015 Aug 22. Review. PubMed PMID: 26421728.

纯度：≥98%

CAS：223132-38-5